Revance Therapeutics, Inc. (RVNC) News
Filter RVNC News Items
RVNC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest RVNC News From Around the Web
Below are the latest news stories about REVANCE THERAPEUTICS INC that investors may wish to consider to help them evaluate RVNC as an investment opportunity.
Analysts Just Slashed Their Revance Therapeutics, Inc. (NASDAQ:RVNC) EPS NumbersOne thing we could say about the analysts on Revance Therapeutics, Inc. ( NASDAQ:RVNC ) - they aren't optimistic... |
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call TranscriptRevance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript November 8, 2023 Revance Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.63 EPS, expectations were $-1.1. Operator: Welcome to the Revance Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following management’s […] |
Q3 2023 Revance Therapeutics Inc Earnings CallQ3 2023 Revance Therapeutics Inc Earnings Call |
Revance Therapeutics, Inc. (RVNC) Reports Q3 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Revance Therapeutics, Inc. (RVNC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
Revance Reports Third Quarter 2023 Financial Results, Provides Corporate UpdateNASHVILLE, November 08, 2023--Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update |
Revance Appoints Erica Jordan as Chief Commercial Officer, AestheticsNASHVILLE, Tenn., November 08, 2023--Revance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics |
Revance to Participate in Upcoming Investor ConferencesNASHVILLE, Tenn., November 06, 2023--Revance to Participate in Upcoming Investor Conferences |
Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NASHVILLE, Tenn., November 01, 2023--Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 |
DAXXIFY® Becomes First Facial Injectable to be Named to TIME’s Best InventionsNASHVILLE, Tenn., October 26, 2023--DAXXIFY® Becomes First Facial Injectable to be Named to TIME’s Best Inventions |
13 Stocks to Buy with Exponential GrowthIn this article, we will take a look at the 13 stocks to buy with exponential growth. To see more such companies, go directly to 5 Stocks to Buy with Exponential Growth. Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish […] |